First child enrolled in Arcutis’ Phase II trial of cream for atopic dermatitis Clinical Trials Arena Source link
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis Dermatology Times Source link
The state of dermatology drug development has been accelerating at an unprecedented rate for the last half-decade, with a myriad of targeted and novel therapy breakthroughs achieved in both common chronic diseases—like atopic dermatitis and psoriasis—and previously under-treated and psychosocially-affecting skin disorders—like alopecia areata and vitiligo. Drug options are becoming more robust, more versatile, and […]
TDM-180935 is a small-molecule drug candidate intended to treat atopic dermatitis. Credit: Kaspars Grinvalds / Shutterstock. Chinese biopharmaceutical company Technoderma Medicines has begun dosing patients in its Phase IIa clinical trial of topical TDM-180935 ointment, a potential treatment for atopic dermatitis (AD). The eight-week trial will assess the two different strengths of the topical medication […]